Nexium, Esomeprazole Newswire

Nexium, Esomeprazole Newswire

Comprehensive Real-Time News Feed for Nexium, Esomeprazole (generic).

Results 1 - 20 of 103 in Nexium, Esomeprazole (generic)

  1. Can Endothelial Injury Provide the Passage to Explain the Vascular...Read the original story

    Thursday Jun 9 | Circulation

    Proton pump inhibitors are a widely used category of drug for past 20 years. Originally requiring a prescription, PPIs were used to treat peptic ulcer and gastroesophageal reflux disease.

    Comment?

  2. Horizon Pharma Announces Issuance Of An Additional Notice Of...Read the original story

    Wednesday Jun 1 | BioSpace

    Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced the issuance of a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/980,639, entitled "Method for Delivering a Pharmaceutical Composition to Patient in Need Thereof" that covers the U.S. approved medicine VIMOVO delayed release tablets. This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed.

    Comment?

  3. Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an...Read the original story w/Photo

    Wednesday Jun 1 | Freshnews

    This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed. The U.S. patent scheduled to issue from this application will expire September 3, 2029.

    Comment?

  4. Global Esomeprazole Magnesium Market Size 2016 Industry Trend and Forecast 2021Read the original story w/Photo

    Tuesday May 31 | PR-inside.com

    The Global And China Esomeprazole Magnesium Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Esomeprazole Magnesium industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

    Comment?

  5. Management of Gastroesophageal Reflux in Infants and ChildrenRead the original story

    May 23, 2016 | Pharmacy Times

    Gastroesophageal reflux, or GER, is defined as the physiologic passage of gastric contents into the esophagus.1 GER, which is caused by transient relaxation of the esophageal sphincter, is a normal physiologic process that occurs at least once daily in healthy infants aged 3 to 4 months. Because this regurgitation in infants is normal, it may occur in association with a wide range of physiologic and pathologic conditions.

    Comment?

  6. Esomeprazole Magnesium: Beware of These Risks and Problems of NexiumRead the original story w/Photo

    May 18, 2016 | News Max

    Esomeprazole magnesium, also known as Nexium, is used to treat acid reflux and other gastrointestinal issues. It belongs to the class of drugs known as proton pump inhibitors.

    Comment?

  7. Synthetic Bio's SYN-004 successful in second mid-stage study; shares up 8% premarketRead the original story w/Photo

    May 16, 2016 | Seeking Alpha

    Micro cap Synthetic Biologics is up 8% premarket on increased volume in response to its announcement of positive top-line results from a second Phase 2a study assessing the ability of SYN-004 to protect the gut microbiome from the unintended effects of certain IV beta-lactam antibiotics, specifically the prevention of C. difficile infection , antibiotic-associated diarrhea and the emergence of antibiotic-resistant organisms, in 14 patients with functioning ileostomies . The study evaluated the effect of a 150 mg dose of SYN-004 to degrade ceftriaxone when administered as monotherapy and in combination with the proton pump inhibitor esomeprazole.

    Comment?

  8. Syntethic Biologics, Inc. Announces Positive Topline Results From...Read the original story w/Photo

    May 15, 2016 | BioSpace

    Results from 14 participants who completed this clinical trial were analyzed to assess the ability of the 150 mg dose of SYN-004 to degrade ceftriaxone when administered alone and with the proton pump inhibitor , esomeprazole. Consistent with previously reported results from the first Phase 2a clinical trial, the second Phase 2a trial demonstrated that the 150 mg dose of SYN-004 degraded residual IV ceftriaxone alone, and in the presence of a PPI, to levels that were near or below detectable in the intestinal chyme of healthy participants with functioning ileostomies.

    Comment?

  9. Heartburn medication speeds up ageing processRead the original story

    May 15, 2016 | Daventry Express

    Congratulations, you're now registered! Let us know what news and updates you want to hear about and we'll send them straight to your inbox. Regular use of an over-the-counter heartburn medication taken by millions of people can speed up the ageing of blood vessels, according to new research.

    Comment?

  10. Chronic Use of Acid-Reflux Drug Could Accelerate Vascular AgingRead the original story w/Photo

    May 12, 2016 | R & D

    Long-term exposure to common, acid reflux drugs known as proton pump inhibitors could speed up the aging of blood vessels, according to a new study published in Circulation Research . The research, conducted by a Houston Methodist Research Institute team, supports recent evidence linking long-term PPI use to increased risk of cardiovascular disease, vascular dementia and renal failure.

    Comment?

  11. Clues to how popular heartburn drug may damage arteriesRead the original story w/Photo

    May 11, 2016 | KYTX-TV News

    A popular over-the-counter heartburn medication accelerated aging of blood vessel cells in lab tests, raising red flags about its long-term effect on heart health, researchers say. Faster aging of blood vessel cells exposed to the antacid Nexium might potentially hinder the tasks these cells perform to prevent heart attack andstroke, the new study suggests.

    Comment?

  12. Clues to How Popular Heartburn Drug Might Harm ArteriesRead the original story w/Photo

    May 11, 2016 | MedicineNet

    A popular over-the-counter heartburn medication accelerated aging of blood vessel cells in lab tests, raising red flags about its long-term effect on heart health, researchers say. Faster aging of blood vessel cells exposed to the antacid Nexium might potentially hinder the tasks these cells perform to prevent heart attack and stroke , the new study suggests.

    Comment?

  13. It's a heartache: heartburn tonic increases ageingRead the original story

    May 11, 2016 | Doncaster Free Press

    Congratulations, you're now registered! Let us know what news and updates you want to hear about and we'll send them straight to your inbox. Regular use of an over-the-counter heartburn medication taken by millions of people can speed up the ageing of blood vessels, according to new research.

    Comment?

  14. Common Antacid Linked to Accelerated Vascular AgingRead the original story

    May 11, 2016 | Health News Digest

    Newswise - Chronic use of some drugs for heartburn and gastroesophageal reflux speeds up the aging of blood vessels, according to a published paper in Circulation Research , an American Heart Association journal. This accelerated aging in humans could lead to increased cardiovascular disease, vascular dementia and renal failure.

    Comment?

  15. Heartburn Drugs Age Blood Vessels: StudyRead the original story w/Photo

    May 11, 2016 | News Max

    A popular over-the-counter heartburn medication accelerated aging of blood vessel cells in lab tests, raising red flags about its long-term effect on heart health, researchers say. Faster aging of blood vessel cells exposed to the antacid Nexium might potentially hinder the tasks these cells perform to prevent heart attack and stroke, the new study suggests.

    Comment?

  16. Chronic use of antacid drugs may speed up aging of blood vesselsRead the original story w/Photo

    May 11, 2016 | Medical News

    Chronic use of some drugs for heartburn and gastroesophageal reflux speeds up the aging of blood vessels, according to a published paper in Circulation Research , an American Heart Association journal. This accelerated aging in humans could lead to increased cardiovascular disease, vascular dementia and renal failure.

    Comment?

  17. Heartburn drug prematurely ages blood vesselsRead the original story w/Photo

    May 11, 2016 | Medical News Today

    Many Americans who suffer from heartburn find relief from the discomfort by taking proton pump inhibitors - an over-the-counter medication. Although these drugs are widely used, concerns are mounting over their long-term effects on the body.

    Comment?

  18. Clues To How Popular Heartburn Drug Might Harm Arteries, Houston Methodist Research Institute StudyRead the original story

    May 10, 2016 | BioSpace

    A popular over-the-counter heartburn medication accelerated aging of blood vessel cells in lab tests, raising red flags about its long-term effect on heart health, researchers say. Faster aging of blood vessel cells exposed to the antacid Nexium might potentially hinder the tasks these cells perform to prevent heart attack and stroke, the new study suggests.

    Comment?

  19. How Popular Heartburn Drug Might Harm ArteriesRead the original story w/Photo

    May 10, 2016 | WebMD

    Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

    Comment?

  20. Gastroesophageal acid reflux control after surgery vs esomeprazole therapyRead the original story

    May 2, 2016 | GastroHep.com

    The most recent issue of Clinical Gastroenterology & Hepatology examines gastroesophageal acid reflux control 5 years after antireflux surgery, compared with long-term esomeprazole therapy. Dr Jan Hatlebakk and colleagues from Norway compared the ability of laparoscopic antireflux surgery and esomeprazole to control esophageal acid exposure, over a 5-year period, in patients with chronic gastroesophageal reflux disease .

    Comment?